SCA
IMPV

SAC Capital Advisors’s Imperva, Inc. IMPV Stock Holding History

SAC Capital Advisors’s Portfolio IMPV Stock Details IMPV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-18,839
Closed -$792K – 2088
2013
Q3 		$792K Buy
+18,839
New +$897K ﹤0.01% 991

Other funds holding IMPV

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

SAC Capital Advisors's IMPV Position: Q4 2013 in Review

SAC Capital Advisors sold out of Imperva, Inc. (IMPV) in Q4 2013, closing a stake of 18,839 shares — an estimated $792K sold.

SAC Capital Advisors first reported a position in IMPV in Q3 2013 and held it in 1 quarter. The position peaked at $792K in Q3 2013. 127 funds tracked by Wall St. Rank hold IMPV as of Q4 2013.

  • SAC Capital Advisors reported no remaining Imperva, Inc. position as of Q4 2013 after selling out during the quarter.
  • SAC Capital Advisors sold 18,839 Imperva, Inc. shares in Q4 2013, an estimated $792K.
  • SAC Capital Advisors first reported a position in Imperva, Inc. in Q3 2013 and held it in 1 quarter.
  • SAC Capital Advisors's Imperva, Inc. position peaked at $792K in Q3 2013.
  • 127 funds tracked by Wall St. Rank held Imperva, Inc. as of Q4 2013.

Based on SAC Capital Advisors's 13F filing for Q4 2013, filed 14 Feb 2014.